The California Institute of Technology of Pasadena has received US Patent No. 8,129,176, "Integrated active flux microfluidic devices and methods." The claimed device is capable of detecting the presence of molecules, such as polynucleotides, proteins, or antigen/antibody complexes, that are correlated to a hybridization signal from an optically detectable reporter associated with the bound molecules. Hybridization probes are immobilized on a substrate exposed to channels of the device that form a closed loop, for circulation of sample to contact complementary probes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.